From Wikipedia, the free encyclopedia
Jump to: navigation, search
Epocrates Essentials homepage

Epocrates, Inc., an athenahealth company is an American company based in San Francisco, California that makes various mobile health software applications under the "Epocrates" name, mostly for health care providers.

Epocrates is recognized for developing the #1 medical application among U.S. physicians and nurse practitioners for clinical content and decision support at the point of care.[1] The app’s regularly updated drug, disease & diagnostic content provide clinicians key information they may need to make informed decisions & deliver better patient care. Epocrates content is created and curated for clinicians by Epocrates-staffed clinicians.

Epocrates has established a loyal network of more than one million health care professionals, including 50 percent of U.S. physicians,[2] who routinely use its intuitive solutions to help streamline workflow and improve patient care.


Epocrates Rx®
The free drug reference app, Epocrates Rx, enables clinicians to instantly access valuable drug prescribing and safety information on their mobile devices right at the point of care, including important information about drug dosing, pricing, adverse reactions and black box warnings, as well as a world-class drug-drug interaction checker, Pill ID tool and a range of helpful medical calculators.

Epocrates® Essentials
Epocrates Essentials is an all-in-one clinical reference suite that offers all the valuable tools of Epocrates Rx, plus drug & disease monographs, diagnostic tools, treatment guidelines, lab tests and panels with reference ranges, tables, and approximate test costs, an Infectious Disease Treatment Selector, and information about alternative medicines—all available from your iPhone, iPad or Android device, so it is easily accessible.[3]

Epocrates Online
EOL is a free, fast, and effective way to find clinical information at the point of care. Unlike other online medical references, Epocrates Online organizes practical, peer-reviewed content with a unique patient-centered approach, providing you with answers, not more questions.

Epocrates CME
Epocrates CME offers more than 100 CME/CE activities for a variety of topics and specialties in the palm of your hand. Earn credits through real-world, case based learning in a highly interactive format.

Epocrates Bugs + Drugs
Epocrates Bugs + Drugs is an antimicrobial susceptibility reference app that provides geolocated bacterial resistance data sourced from athenahealth's cloud-based EHR to help support clinical decision-making at the point of care.

The company markets both free and multiple paid versions of the core app, Epocrates.[4] It receives additional revenue from pharmaceutical companies.[5]

The company was founded in 1998.[6] Early versions of Epocrates ran on Palm devices[7] and desktop computers. The user base was 525,000 users worldwide (including 200,000 doctors in the United States) in 2006.[5] As of 2006, the company was also active in the United Kingdom, Canada, Germany and Spain.[5] Among its competitors is WebMD.[5] By 2010, the company said it had 1 million users worldwide, including 40% of the physicians in the United States,[8] and that it employed more than 250 people.[6] Today, Epocrates has established a loyal network of more than one million health care professionals, including 50 percent of U.S. physicians.[2]

Management team[edit]

Rob Cosinuke – President, Epocrates and CMO, athenahealth, Inc.

Rob Cosinuke joined Epocrates from athenahealth after the company acquired Epocrates in March 2013. Mr. Cosinuke was a co-founder of Digitas, LLC, a leading interactive and database marketing advertising agency that was acquired by Publicis Group SA. From 1991 to 2006, he was employed by Digitas, most recently as President of Digitas, Boston. He also served as President of Global Capabilities, Digitas. He has a Bachelor of Arts from Haverford College and an M.B.A. from Harvard Business School.[9]

Heather Gervais – Senior Vice President, Commercial Operations

Heather Gervais is a seasoned healthcare information technology and marketing executive specializing in cross-functional team leadership. In her role as Senior Vice President of Commercial Operations at Epocrates, Heather Gervais helped to steward the successful acquisition of Epocrates by athenahealth in 2013 and continues to work with the company's R&D, Medical Information, Sales, Marketing, Data, Operations and Finance teams to deliver novel, high-impact digital marketing solutions to strategic business partners.[9]

Dr. Anne Meneghetti – Executive Director of Medical Information

Prior to joining Epocrates, Dr. Anne Meneghetti served as the Vice President for Health Policy at Boston-based health plan Blue Cross Blue Shield of Massachusetts. She has extensive experience creating radio, print and electronic communications for healthcare professionals and consumers.

She obtained her M.D. from the University of Texas Southwestern Medical School before completing an Internal Medicine internship and residency at the University of Michigan Medical Center. She maintains board certifications in Internal Medicine, Pulmonary Medicine and Critical Care. [9]

Abbe Don – Vice President of User Experience

As Vice President of User Experience at Epocrates, Abbe Don is responsible for creating a contemporary, innovative end-to-end mobile customer experience for caregivers. Prior to joining Epocrates in June 2013, she spent 25 years focused on interaction design in the consumer space for companies such as Apple, The Walt Disney Company, Hewlett-Packard, and IDEO. Abbe Don holds a Master's degree in Interactive Telecommunications from New York University and a Bachelor of Arts degree from Pomona College.[9]


Epocrates' early funders included Bay City Capital, Draper Fisher Jurvetson, Interwest Partners, Sprout Group and Three Arch Partners.[5]

After a 2008 public offering was put on hold,[10] Epocrates filed a registration statement again in July 2010 to raise $75 million.[8]

On January 7, 2013, it was announced that athenahealth is acquiring Epocrates for about $293 million.[11]


  1. ^ "Epocrates App is #1 Among U.S.Physicians". Executive Insight. Retrieved 14 January 2014. 
  2. ^ a b "Epocrates Media Room". Epocrates.com. Retrieved 14 January 2014. 
  3. ^ "Epocrates, Inc.". Hoovers. 
  4. ^ "Last Day to Get Epocrates Essentials for Free for Medical Students". Medgadget. August 31, 2010. 
  5. ^ a b c d e Chris Rauber (August 18, 2006). "Epocrates putting drug info into docs' pockets". San Francisco Business Times. 
  6. ^ a b "Media Room". Epocrates. 
  7. ^ Milt Freudenheim (January 8, 2001). "Digital Doctoring; The Race Is On to Put a Computer Into Every Physician's Hand". New York Times. 
  8. ^ a b "Epocrates files to raise up to $75M in IPO". San Francisco Business Times. July 16, 2010. 
  9. ^ a b c d "Leadership Team". Retrieved 14 January 2014. 
  10. ^ Chris Rauber (September 19, 2008). "Epocrates’ IPO on hold". San Francisco Business Times. 
  11. ^ "AthenaHealth Acquires Epocrates, the Angry Birds of Health". Bloomberg. January 7, 2013. 

External links[edit]